We thus designed the Glucose Monitoring and Intervention in Insulin-treated Type 2 Diabetes Patients (GEMINI-T2D) study to examine the efficacy and safety of a web-based platform that incorporates monitoring and insulin titration recommendations based on a built-in algorithm in patients treated with insulin. This evidence concerns the gene INS and type 2 diabetes mellitus.